New aspects of amino acid metabolism in cancer

An abundant supply of amino acids is important for cancers to sustain their proliferative drive. Alongside their direct role as substrates for protein synthesis, they can have roles in energy generation, driving the synthesis of nucleosides and maintenance of cellular redox homoeostasis. As cancer c...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of cancer Vol. 122; no. 2; pp. 150 - 156
Main Authors Vettore, Lisa, Westbrook, Rebecca L., Tennant, Daniel A.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2020
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An abundant supply of amino acids is important for cancers to sustain their proliferative drive. Alongside their direct role as substrates for protein synthesis, they can have roles in energy generation, driving the synthesis of nucleosides and maintenance of cellular redox homoeostasis. As cancer cells exist within a complex and often nutrient-poor microenvironment, they sometimes exist as part of a metabolic community, forming relationships that can be both symbiotic and parasitic. Indeed, this is particularly evident in cancers that are auxotrophic for particular amino acids. This review discusses the stromal/cancer cell relationship, by using examples to illustrate a number of different ways in which cancer cells can rely on and contribute to their microenvironment – both as a stable network and in response to therapy. In addition, it examines situations when amino acid synthesis is driven through metabolic coupling to other reactions, and synthesis is in excess of the cancer cell’s proliferative demand. Finally, it highlights the understudied area of non-proteinogenic amino acids in cancer metabolism and their potential role.
AbstractList An abundant supply of amino acids is important for cancers to sustain their proliferative drive. Alongside their direct role as substrates for protein synthesis, they can have roles in energy generation, driving the synthesis of nucleosides and maintenance of cellular redox homoeostasis. As cancer cells exist within a complex and often nutrient-poor microenvironment, they sometimes exist as part of a metabolic community, forming relationships that can be both symbiotic and parasitic. Indeed, this is particularly evident in cancers that are auxotrophic for particular amino acids. This review discusses the stromal/cancer cell relationship, by using examples to illustrate a number of different ways in which cancer cells can rely on and contribute to their microenvironment – both as a stable network and in response to therapy. In addition, it examines situations when amino acid synthesis is driven through metabolic coupling to other reactions, and synthesis is in excess of the cancer cell’s proliferative demand. Finally, it highlights the understudied area of non-proteinogenic amino acids in cancer metabolism and their potential role.
An abundant supply of amino acids is important for cancers to sustain their proliferative drive. Alongside their direct role as substrates for protein synthesis, they can have roles in energy generation, driving the synthesis of nucleosides and maintenance of cellular redox homoeostasis. As cancer cells exist within a complex and often nutrient-poor microenvironment, they sometimes exist as part of a metabolic community, forming relationships that can be both symbiotic and parasitic. Indeed, this is particularly evident in cancers that are auxotrophic for particular amino acids. This review discusses the stromal/cancer cell relationship, by using examples to illustrate a number of different ways in which cancer cells can rely on and contribute to their microenvironment – both as a stable network and in response to therapy. In addition, it examines situations when amino acid synthesis is driven through metabolic coupling to other reactions, and synthesis is in excess of the cancer cell’s proliferative demand. Finally, it highlights the understudied area of non-proteinogenic amino acids in cancer metabolism and their potential role.
An abundant supply of amino acids is important for cancers to sustain their proliferative drive. Alongside their direct role as substrates for protein synthesis, they can have roles in energy generation, driving the synthesis of nucleosides and maintenance of cellular redox homoeostasis. As cancer cells exist within a complex and often nutrient-poor microenvironment, they sometimes exist as part of a metabolic community, forming relationships that can be both symbiotic and parasitic. Indeed, this is particularly evident in cancers that are auxotrophic for particular amino acids. This review discusses the stromal/cancer cell relationship, by using examples to illustrate a number of different ways in which cancer cells can rely on and contribute to their microenvironment - both as a stable network and in response to therapy. In addition, it examines situations when amino acid synthesis is driven through metabolic coupling to other reactions, and synthesis is in excess of the cancer cell's proliferative demand. Finally, it highlights the understudied area of non-proteinogenic amino acids in cancer metabolism and their potential role.An abundant supply of amino acids is important for cancers to sustain their proliferative drive. Alongside their direct role as substrates for protein synthesis, they can have roles in energy generation, driving the synthesis of nucleosides and maintenance of cellular redox homoeostasis. As cancer cells exist within a complex and often nutrient-poor microenvironment, they sometimes exist as part of a metabolic community, forming relationships that can be both symbiotic and parasitic. Indeed, this is particularly evident in cancers that are auxotrophic for particular amino acids. This review discusses the stromal/cancer cell relationship, by using examples to illustrate a number of different ways in which cancer cells can rely on and contribute to their microenvironment - both as a stable network and in response to therapy. In addition, it examines situations when amino acid synthesis is driven through metabolic coupling to other reactions, and synthesis is in excess of the cancer cell's proliferative demand. Finally, it highlights the understudied area of non-proteinogenic amino acids in cancer metabolism and their potential role.
Author Tennant, Daniel A.
Vettore, Lisa
Westbrook, Rebecca L.
Author_xml – sequence: 1
  givenname: Lisa
  surname: Vettore
  fullname: Vettore, Lisa
  organization: Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston
– sequence: 2
  givenname: Rebecca L.
  surname: Westbrook
  fullname: Westbrook, Rebecca L.
  organization: Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston
– sequence: 3
  givenname: Daniel A.
  orcidid: 0000-0003-0499-2732
  surname: Tennant
  fullname: Tennant, Daniel A.
  email: d.tennant@bham.ac.uk
  organization: Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31819187$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9LHTEUxUNR6tP2A7gpA27cjN78m0k2BXnUVhDd6DpkMnc0MpO8JvMUv33zeNpaod3kEvI7h5N79slOiAEJOaRwQoGr0yyooE0NVNfQMKjlB7KgkrOaKtbukAUAtDVoBntkP-eHctWg2o9kj1NFNVXtgpxc4VNl8wrdnKs4VHbyIVbW-b6acLZdHH2eKh8qZ4PD9InsDnbM-PllHpDb8283yx_15fX3i-XZZe0kb-ZaILSUa-t4D50UQz90jHaNVIzKQaHWfU-1kE5oxIEPhWBcglN9oxRIpfgB-br1Xa27CXuHYU52NKvkJ5ueTbTe_P0S_L25i4-mBcmYaIrB8YtBij_XmGcz-exwHG3AuM6GccZFy5hkBT16hz7EdQrle4USHJgsZ6G-vE30O8rrKgvQbgGXYs4JB-P8bGcfNwH9aCiYTWlmW5oppZlNaUYWJX2nfDX_n4ZtNbmw4Q7Tn9D_Fv0C5mamwg
CitedBy_id crossref_primary_10_1097_AS9_0000000000000224
crossref_primary_10_3390_ijms241310668
crossref_primary_10_1038_s41598_022_04994_6
crossref_primary_10_1038_s41698_023_00434_4
crossref_primary_10_3390_biology12081131
crossref_primary_10_1155_2020_2061024
crossref_primary_10_3389_fonc_2024_1286896
crossref_primary_10_1186_s12929_024_01013_w
crossref_primary_10_1021_acs_jproteome_4c00529
crossref_primary_10_3390_ijms231810587
crossref_primary_10_1002_anie_202301910
crossref_primary_10_3389_fonc_2022_972984
crossref_primary_10_3390_pharmaceutics14061303
crossref_primary_10_3390_ijms24054587
crossref_primary_10_1155_2021_8621464
crossref_primary_10_1016_j_cellsig_2024_111565
crossref_primary_10_1021_acsomega_3c07424
crossref_primary_10_3389_fmolb_2022_955705
crossref_primary_10_1016_j_canlet_2020_12_041
crossref_primary_10_1186_s40246_024_00635_3
crossref_primary_10_1007_s12032_024_02424_3
crossref_primary_10_3892_mmr_2024_13255
crossref_primary_10_2174_1871520620666200824114816
crossref_primary_10_1186_s12014_023_09443_8
crossref_primary_10_1016_j_microc_2023_108452
crossref_primary_10_1038_s41388_022_02408_5
crossref_primary_10_18632_aging_205951
crossref_primary_10_1089_cbr_2024_0002
crossref_primary_10_1016_j_pathol_2024_11_007
crossref_primary_10_3390_ijms23126510
crossref_primary_10_1093_toxres_tfab023
crossref_primary_10_3803_EnM_2020_35_2_227
crossref_primary_10_1002_mco2_218
crossref_primary_10_1039_D4FO05606J
crossref_primary_10_1016_j_canlet_2020_04_016
crossref_primary_10_1016_j_cmet_2025_01_021
crossref_primary_10_37748_2687_0533_2020_1_4_5
crossref_primary_10_3389_fonc_2023_1049147
crossref_primary_10_1186_s12943_024_02218_1
crossref_primary_10_1186_s12866_022_02458_5
crossref_primary_10_3390_ijms21176156
crossref_primary_10_3389_fmed_2022_945602
crossref_primary_10_1007_s12672_023_00634_1
crossref_primary_10_1016_j_heliyon_2023_e16156
crossref_primary_10_3389_fendo_2023_1248575
crossref_primary_10_3390_metabo14060297
crossref_primary_10_1155_2022_2469592
crossref_primary_10_7717_peerj_13272
crossref_primary_10_3390_ijms231911975
crossref_primary_10_1038_s41598_023_42541_z
crossref_primary_10_3389_fgene_2022_951461
crossref_primary_10_3389_fonc_2022_1101503
crossref_primary_10_1111_cas_15355
crossref_primary_10_3390_diagnostics10090689
crossref_primary_10_1186_s12943_025_02263_4
crossref_primary_10_1007_s00432_023_04985_8
crossref_primary_10_1017_jns_2021_83
crossref_primary_10_3390_metabo14090490
crossref_primary_10_1007_s11306_022_01964_x
crossref_primary_10_1186_s12885_024_13374_4
crossref_primary_10_3389_fonc_2021_694526
crossref_primary_10_3389_fonc_2023_1186539
crossref_primary_10_1007_s10555_021_10012_4
crossref_primary_10_1038_s12276_022_00765_5
crossref_primary_10_1002_jssc_202200953
crossref_primary_10_3390_biom12111590
crossref_primary_10_1016_j_bbcan_2020_188442
crossref_primary_10_3389_fonc_2022_1001318
crossref_primary_10_3389_fcell_2020_603837
crossref_primary_10_3390_ijms22137068
crossref_primary_10_3390_ph14070648
crossref_primary_10_1016_j_arr_2020_101249
crossref_primary_10_3390_ijms25126328
crossref_primary_10_1186_s12964_024_01760_1
crossref_primary_10_1111_1541_4337_12835
crossref_primary_10_3389_fendo_2020_00555
crossref_primary_10_3390_ijms232213940
crossref_primary_10_3390_molecules28237699
crossref_primary_10_1002_nbm_4935
crossref_primary_10_1021_accountsmr_2c00106
crossref_primary_10_1016_j_theriogenology_2024_03_002
crossref_primary_10_1021_acs_jpcc_3c01164
crossref_primary_10_3390_cancers13030399
crossref_primary_10_1038_s42255_023_00936_2
crossref_primary_10_3390_metabo14120708
crossref_primary_10_3389_fcell_2021_684036
crossref_primary_10_1016_j_apsb_2024_07_004
crossref_primary_10_3390_cancers13030393
crossref_primary_10_1146_annurev_nutr_120420_032437
crossref_primary_10_3390_ijms23158761
crossref_primary_10_31083_j_fbl2904137
crossref_primary_10_3390_biomedicines10071741
crossref_primary_10_3390_biom10060906
crossref_primary_10_1016_j_tem_2021_03_003
crossref_primary_10_1038_s41467_020_19313_8
crossref_primary_10_1080_19336918_2021_1935407
crossref_primary_10_1002_mco2_44
crossref_primary_10_3390_cimb47010004
crossref_primary_10_1016_j_bioorg_2025_108349
crossref_primary_10_1007_s10549_023_07182_w
crossref_primary_10_1016_j_ijpharm_2022_122370
crossref_primary_10_3390_cimb45090474
crossref_primary_10_3390_cancers13246224
crossref_primary_10_1021_acs_jproteome_0c00006
crossref_primary_10_1007_s44211_024_00670_z
crossref_primary_10_1186_s12920_022_01380_z
crossref_primary_10_7717_peerj_13632
crossref_primary_10_1182_bloodadvances_2023010786
crossref_primary_10_1186_s43094_024_00712_3
crossref_primary_10_1080_00032719_2021_1917592
crossref_primary_10_1186_s40364_024_00562_4
crossref_primary_10_1182_bloodadvances_2020001639
crossref_primary_10_62347_ZSOO2247
crossref_primary_10_1186_s40364_024_00622_9
crossref_primary_10_3390_cancers13174281
crossref_primary_10_3390_metabo14010028
crossref_primary_10_1016_j_molmet_2024_101952
crossref_primary_10_1021_acs_biochem_0c00354
crossref_primary_10_3892_mmr_2023_13106
crossref_primary_10_2217_epi_2023_0251
crossref_primary_10_3389_fonc_2022_999643
crossref_primary_10_1016_j_jprot_2024_105297
crossref_primary_10_3389_fonc_2025_1565090
crossref_primary_10_1038_s41419_023_05930_w
crossref_primary_10_1016_j_nanoso_2025_101459
crossref_primary_10_1186_s12885_025_13866_x
crossref_primary_10_3390_genes13122343
crossref_primary_10_1080_23723556_2024_2377404
crossref_primary_10_1016_j_bbcan_2022_188839
crossref_primary_10_3390_metabo13070872
crossref_primary_10_3892_ijmm_2023_5282
crossref_primary_10_2478_s11756_021_00678_0
crossref_primary_10_1038_s41416_019_0667_3
crossref_primary_10_2174_0929867328666210806110857
crossref_primary_10_1016_j_nut_2024_112427
crossref_primary_10_1097_MD_0000000000040189
crossref_primary_10_1186_s40168_021_01208_5
crossref_primary_10_3389_fcell_2021_731790
crossref_primary_10_1016_j_foodchem_2025_143206
crossref_primary_10_1016_j_mcpro_2022_100435
crossref_primary_10_3390_metabo12070643
crossref_primary_10_3390_ijms24010012
crossref_primary_10_3390_cells9092028
crossref_primary_10_1002_advs_202309424
crossref_primary_10_1016_j_heliyon_2024_e37985
crossref_primary_10_3389_fbioe_2022_943906
crossref_primary_10_1016_j_cmet_2023_10_002
crossref_primary_10_3390_life13091823
crossref_primary_10_1039_D2CE00174H
crossref_primary_10_1016_j_cej_2024_155071
crossref_primary_10_1016_j_adcanc_2022_100042
crossref_primary_10_1080_00365513_2024_2392241
crossref_primary_10_1016_j_bbadis_2024_167612
crossref_primary_10_1080_10826068_2021_1983831
crossref_primary_10_3389_fcell_2022_813581
crossref_primary_10_1038_s41467_023_42458_1
crossref_primary_10_3390_cancers13020272
crossref_primary_10_1016_j_semcancer_2022_07_005
crossref_primary_10_1155_2022_7884740
crossref_primary_10_3390_ijms26051888
crossref_primary_10_3390_molecules29174240
crossref_primary_10_1038_s41417_022_00470_5
crossref_primary_10_1038_s41392_023_01569_3
crossref_primary_10_1186_s40168_023_01707_7
crossref_primary_10_1021_acssensors_2c01342
crossref_primary_10_1210_jendso_bvac061
crossref_primary_10_1007_s00280_022_04478_4
crossref_primary_10_1007_s10528_023_10502_w
crossref_primary_10_1039_D2AN01222G
crossref_primary_10_1158_0008_5472_CAN_23_2910
crossref_primary_10_3390_cancers15082385
crossref_primary_10_1016_j_bios_2024_116633
crossref_primary_10_3390_cancers16183169
crossref_primary_10_1016_j_bbamcr_2020_118944
crossref_primary_10_3389_fphar_2020_01183
crossref_primary_10_1038_s41598_023_43983_1
crossref_primary_10_1039_D0SC02221G
crossref_primary_10_1016_j_canlet_2024_216756
crossref_primary_10_3389_fendo_2022_993081
crossref_primary_10_1002_smll_202311228
crossref_primary_10_1016_j_microc_2024_110313
crossref_primary_10_3390_pharmaceutics14102207
crossref_primary_10_3390_cancers14030725
crossref_primary_10_1002_mc_23349
crossref_primary_10_1016_j_biosx_2024_100510
crossref_primary_10_1016_j_talanta_2024_126465
crossref_primary_10_1016_j_jcyt_2025_01_002
crossref_primary_10_1007_s13205_023_03590_3
crossref_primary_10_1021_acs_analchem_3c00909
crossref_primary_10_62347_GLSY2976
crossref_primary_10_1007_s11306_023_02024_8
crossref_primary_10_1039_D2SC03326G
crossref_primary_10_1080_10409238_2020_1832438
crossref_primary_10_1016_j_tranon_2023_101632
crossref_primary_10_3390_cancers13123012
crossref_primary_10_1016_j_jpba_2024_116622
crossref_primary_10_3390_metabo11090627
crossref_primary_10_3389_fcell_2021_714755
crossref_primary_10_3389_fonc_2022_914332
crossref_primary_10_1002_1878_0261_13588
crossref_primary_10_1016_j_jprot_2020_103875
crossref_primary_10_3389_fphar_2024_1516650
crossref_primary_10_3389_fgene_2022_982162
crossref_primary_10_1016_j_exphem_2025_104710
crossref_primary_10_1007_s10528_024_10733_5
crossref_primary_10_7717_peerj_11121
crossref_primary_10_1007_s00726_023_03250_z
crossref_primary_10_3390_ijms22031444
crossref_primary_10_1038_s41419_024_06435_w
crossref_primary_10_3390_genes15101316
crossref_primary_10_1007_s00262_024_03716_3
crossref_primary_10_3390_cancers13071716
crossref_primary_10_1158_1541_7786_MCR_22_0843
crossref_primary_10_3390_jpm14030305
crossref_primary_10_1016_j_bioorg_2024_107212
crossref_primary_10_1016_j_celrep_2024_114552
crossref_primary_10_1016_j_saa_2023_122557
crossref_primary_10_1007_s10637_024_01438_y
crossref_primary_10_1021_acs_analchem_2c05351
crossref_primary_10_1016_j_ejca_2023_03_002
crossref_primary_10_3390_ph13100292
crossref_primary_10_20473_jr_v9_I_2_2023_80_86
crossref_primary_10_1016_j_jep_2024_118260
crossref_primary_10_3390_ph16060861
crossref_primary_10_3390_ijms21218107
crossref_primary_10_1016_j_apsb_2024_04_021
crossref_primary_10_1038_s41598_021_93003_3
crossref_primary_10_1097_MD_0000000000034365
crossref_primary_10_1007_s10495_023_01875_9
crossref_primary_10_1016_j_jconrel_2024_12_073
crossref_primary_10_7717_peerj_15302
crossref_primary_10_2174_1389200221666200610173724
crossref_primary_10_1134_S0006297923140018
crossref_primary_10_1016_j_pep_2021_105820
crossref_primary_10_1093_bioinformatics_btac222
crossref_primary_10_1016_j_phymed_2023_154772
crossref_primary_10_3390_chemosensors11050259
crossref_primary_10_1099_jgv_0_001942
crossref_primary_10_1002_ange_202301910
crossref_primary_10_1007_s10555_021_10006_2
crossref_primary_10_1016_j_bbrc_2024_150046
crossref_primary_10_1021_acssensors_4c03174
crossref_primary_10_1038_s41420_020_00341_8
crossref_primary_10_1002_cac2_12519
crossref_primary_10_1016_j_neubiorev_2025_106035
crossref_primary_10_1038_s41419_024_06938_6
crossref_primary_10_1186_s40364_024_00593_x
crossref_primary_10_1016_j_exer_2025_110315
crossref_primary_10_3389_fonc_2022_790933
crossref_primary_10_1038_s41419_020_03020_9
crossref_primary_10_3390_cancers12092576
crossref_primary_10_1002_path_5828
crossref_primary_10_1007_s00360_023_01506_4
crossref_primary_10_1016_j_mocell_2025_100198
crossref_primary_10_1016_j_tibs_2023_03_004
crossref_primary_10_1038_s41586_024_08335_7
crossref_primary_10_1158_1078_0432_CCR_23_2934
crossref_primary_10_1016_j_jid_2024_11_007
crossref_primary_10_1093_burnst_tkad047
crossref_primary_10_3390_microorganisms9081548
crossref_primary_10_1016_j_ab_2022_114698
crossref_primary_10_1016_j_jpha_2020_11_009
crossref_primary_10_3390_ijms21051892
crossref_primary_10_1038_s41592_024_02208_7
crossref_primary_10_1186_s12935_022_02775_9
crossref_primary_10_3389_fphar_2021_596652
crossref_primary_10_1021_acs_jmedchem_4c00774
crossref_primary_10_1186_s40170_021_00247_8
crossref_primary_10_1186_s13046_024_03239_w
crossref_primary_10_1002_wdev_394
crossref_primary_10_3390_metabo11020112
crossref_primary_10_3389_fgene_2023_1084275
crossref_primary_10_1038_s41598_021_83343_5
crossref_primary_10_3389_fonc_2023_1070069
crossref_primary_10_1021_acscatal_3c01363
crossref_primary_10_1038_s41392_024_01777_5
crossref_primary_10_1080_02656736_2023_2270654
crossref_primary_10_1002_cnr2_2131
crossref_primary_10_1152_ajpregu_00217_2024
crossref_primary_10_1186_s13048_025_01633_2
crossref_primary_10_1016_j_canlet_2022_215766
crossref_primary_10_3389_fmolb_2021_769661
crossref_primary_10_3390_cancers15102862
crossref_primary_10_3389_fmolb_2023_1286673
crossref_primary_10_1016_j_ijbiomac_2024_136974
crossref_primary_10_1007_s00726_021_03052_1
crossref_primary_10_1155_2022_9671594
crossref_primary_10_3390_cancers12102780
crossref_primary_10_1039_D4CS00679H
crossref_primary_10_1631_jzus_B2200144
crossref_primary_10_3389_fonc_2024_1305684
crossref_primary_10_1016_j_semcancer_2020_12_019
crossref_primary_10_1021_acsomega_1c05361
Cites_doi 10.1007/s00253-013-5118-0
10.1038/nature08617
10.1158/0008-5472.CAN-12-3609-T
10.1038/ncomms11457
10.1182/blood-2016-01-690743
10.1016/j.celrep.2018.02.084
10.1172/JCI30235
10.1371/journal.pone.0045190
10.1016/j.jplph.2006.03.010
10.1007/s00726-006-0407-x
10.1111/j.1365-2362.1988.tb01049.x
10.1016/j.trecan.2019.04.002
10.1111/j.1432-1033.1982.tb05851.x
10.4143/crt.2013.45.4.251
10.1038/nature19084
10.1016/S0021-9258(19)85901-X
10.1126/science.aam9305
10.1038/s41586-019-0977-x
10.1016/S0891-5849(99)00176-8
10.1056/NEJMoa0808710
10.1089/ars.2012.5074
10.1038/s41556-018-0118-z
10.1038/ncomms16031
10.1074/jbc.M115.700534
10.2741/s296
10.1039/b201027p
10.1038/ncomms9784
10.1111/php.12290
10.1093/abbs/gmu004
10.1007/BF02252617
10.1158/0008-5472.CAN-14-2211
10.1016/j.cell.2015.07.016
10.1126/sciadv.aau7314
10.1038/ncb3233
10.1385/CBB:36:2-3:155
10.1093/emboj/cdf656
10.1113/jphysiol.2002.026500
10.1038/ncomms15267
10.1007/s13277-014-2644-z
10.18632/oncotarget.24168
10.1158/1078-0432.CCR-06-1101
10.1016/j.ejca.2012.09.003
10.1016/j.cmet.2016.10.011
10.1126/science.3090687
10.1093/carcin/bgy033
10.1242/jcs.176149
10.1097/00008390-199209000-00007
10.1172/JCI1909
10.18632/oncotarget.22099
10.1016/j.tcb.2017.05.001
10.1146/annurev.biochem.75.103004.142520
10.1038/ncb3272
10.1007/s10495-013-0877-8
10.1038/nrc2817
10.1016/j.cmet.2018.09.012
10.1038/s41467-018-03777-w
10.1002/cncr.20057
10.1016/j.tplants.2009.11.009
10.1038/sj.bjc.6604485
10.1038/nature12138
10.1074/jbc.R117.819060
10.1113/expphysiol.1985.sp002935
10.1158/ajc.1937.510
10.1038/onc.2013.264
10.1002/jmri.25221
10.1038/sj.bjc.6600481
10.1016/j.cell.2017.03.023
10.3390/ijms19041099
10.1016/j.cell.2008.11.044
10.1038/cddis.2012.83
10.1007/s12022-018-9516-9
10.1073/pnas.1903506116
10.1016/j.cmet.2018.07.005
10.1016/j.cell.2015.07.017
10.1074/jbc.R700042200
10.1158/0008-5472.CAN-12-4402
10.1126/sciadv.1601273
10.1016/j.ccr.2013.08.020
ContentType Journal Article
Copyright The Author(s) 2019
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2019
– notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TO
7U9
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/s41416-019-0620-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student

MEDLINE

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-1827
EndPage 156
ExternalDocumentID PMC7052246
31819187
10_1038_s41416_019_0620_5
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Cancer Research UK (CRUK)
  grantid: C42109/A26982
  funderid: https://doi.org/10.13039/501100000289
– fundername: Cancer Research UK
  grantid: 24757
– fundername: ;
  grantid: C42109/A26982
GroupedDBID ---
-Q-
0R~
23N
36B
39C
4.4
406
53G
5GY
5RE
6J9
70F
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWTL
AAYZH
AAZLF
ABAKF
ABLJU
ABOCM
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACPRK
ACRQY
ACZOJ
ADBBV
ADFRT
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AN0
AOIJS
ASPBG
AVWKF
AXYYD
AZFZN
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
E3Z
EAP
EBLON
EBS
EE.
EIOEI
EMB
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIGPU
FRJ
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IH2
IWAJR
JSO
JZLTJ
KQ8
M1P
M7P
NAO
NAPCQ
NQJWS
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
WH7
WOW
~02
AAFWJ
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
.55
.GJ
8WZ
A6W
ABAWZ
ABDBF
ABRTQ
ACUHS
AI.
B0M
CAG
CGR
COF
CUY
CVF
EAD
EAS
EBC
EBD
ECM
EIF
EJD
EMK
EMOBN
EPL
FIZPM
J5H
M41
NPM
PJZUB
PPXIY
PQGLB
SV3
TUS
UDS
VH1
X7M
Y6R
ZGI
~8M
3V.
7TO
7U9
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c536t-4e07139ac3d0b54fdfb21b658215f8e99dd1945c49eef3f54f2350c8d68805883
IEDL.DBID 7X7
ISSN 0007-0920
1532-1827
IngestDate Thu Aug 21 13:59:27 EDT 2025
Fri Jul 11 07:06:23 EDT 2025
Fri Jul 25 09:00:02 EDT 2025
Mon Jul 21 06:05:03 EDT 2025
Tue Jul 01 01:29:50 EDT 2025
Thu Apr 24 22:59:47 EDT 2025
Fri Feb 21 02:39:36 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-4e07139ac3d0b54fdfb21b658215f8e99dd1945c49eef3f54f2350c8d68805883
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-0499-2732
OpenAccessLink https://www.nature.com/articles/s41416-019-0620-5
PMID 31819187
PQID 2343025343
PQPubID 41855
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7052246
proquest_miscellaneous_2323472252
proquest_journals_2343025343
pubmed_primary_31819187
crossref_citationtrail_10_1038_s41416_019_0620_5
crossref_primary_10_1038_s41416_019_0620_5
springer_journals_10_1038_s41416_019_0620_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle British journal of cancer
PublicationTitleAbbrev Br J Cancer
PublicationTitleAlternate Br J Cancer
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Birsoy, Wang, Chen, Freinkman, Abu-Remaileh, Sabatini (CR25) 2015; 162
Vicente, Fuster-Garcia, Tortajada, Garcia-Gomez, Davies, Natarajan (CR72) 2013; 49
Kelty, Brown, Reed, Ackroyd (CR74) 2002; 1
Shi, Sun, Shi, Zuo, Cui, Ni (CR47) 2015; 36
Spinelli, Yoon, Ringel, Jeanfavre, Clish, Haigis (CR62) 2017; 358
Olivares, Mayers, Gouirand, Torrence, Gicquel, Borge (CR36) 2017; 8
Newsholme, Crabtree, Ardawi (CR38) 1985; 70
Szabados, Savoure (CR48) 2010; 15
Kohe, Bennett, Gill, Wilson, McConville, Peet (CR71) 2018; 9
Wu, Wang, Zhao, Shi, Jin, Wan (CR34) 2013; 32
Mohrenz, Antonietti, Pusch, Capper, Balss, Voigt (CR46) 2013; 18
Wang, Shi, Li, Zeng, Fan, Sun (CR20) 2014; 98
Tran, Mu, Adachi, Adachi, Taketani (CR75) 2014; 90
Tardito, Oudin, Ahmed, Fack, Keunen, Zheng (CR12) 2015; 17
Groen, Sips, Vervoorn, Tager (CR39) 1982; 122
De Ingeniis, Ratnikov, Richardson, Scott, Aza-Blanc, De (CR49) 2012; 7
Meiser, Schuster, Pietzke, Vande Voorde, Athineos, Oizel (CR65) 2018; 9
Griffith (CR59) 1999; 27
Elia, Rossi, Stegen, Broekaert, Doglioni, van Gorsel (CR40) 2019; 568
Broer, Rahimi, Broer (CR53) 2016; 291
Ehsanipour, Sheng, Behan, Wang, Butturini, Avramis (CR22) 2013; 73
Kamphorst, Nofal, Commisso, Hackett, Lu, Grabocka (CR31) 2015; 75
Tiruppathi, Brandsch, Miyamoto, Ganapathy, Leibach (CR70) 1992; 263
Tennant, Duran, Gottlieb (CR14) 2010; 10
Iwamoto, Mihara, Downing, Pui, Campana (CR21) 2007; 117
Delage, Luong, Maharaj, O’Riain, Syed, Crook (CR19) 2012; 3
Yan, Parsons, Jin, McLendon, Rasheed, Yuan (CR43) 2009; 360
Burg, Ferraris (CR67) 2008; 283
Timmerman, Holton, Yuneva, Louie, Padro, Daemen (CR60) 2013; 24
Elia, Broekaert, Christen, Boon, Radaelli, Orth (CR35) 2017; 8
Lo, Ling, Wang, Gout (CR58) 2008; 99
Yoshikawa, Tsuchihashi, Ishimoto, Yae, Motohara, Sugihara (CR61) 2013; 73
Bisdas, Chadzynski, Braun, Schittenhelm, Skardelly, Hagberg (CR45) 2016; 44
Commisso, Davidson, Soydaner-Azeloglu, Parker, Kamphorst, Hackett (CR30) 2013; 497
Lussey-Lepoutre, Hollinshead, Ludwig, Menara, Morin, Castro-Vega (CR17) 2015; 6
Suzuki, Suzuki, Wada, Saigo, Watanabe (CR66) 2002; 21
Sugimura, Ohno, Kusuyama, Azuma (CR2) 1992; 2
Krall, Xu, Graeber, Braas, Christofk (CR55) 2016; 7
Mates, Segura, Alonso, Marquez (CR68) 2012; 4
Bloomfield, Kay (CR27) 2016; 129
Khadeir, Szyszko, Szlosarek (CR6) 2017; 8
Yang, Achreja, Yeung, Mangala, Jiang, Han (CR15) 2016; 24
Cardaci, Zheng, MacKay, van den Broek, MacKenzie, Nixon (CR18) 2015; 17
Bannai, Kitamura (CR56) 1980; 255
Martinez, Frank, Diez-Tejedor, Hernanz (CR37) 1993; 6
Phillips, Sheaff, Szlosarek (CR7) 2013; 45
Tajan, Hock, Blagih, Robertson, Labuschagne, Kruiswijk (CR24) 2018; 28
Nicklin, Bergman, Zhang, Triantafellow, Wang, Nyfeler (CR54) 2009; 136
Hollinshead, Munford, Eales, Bardella, Li, Escribano-Gonzalez (CR42) 2018; 22
Tejeda-Muñoz, Albrecht, Bui, De Robertis (CR32) 2019; 116
Dang, White, Gross, Bennett, Bittinger, Driggers (CR44) 2009; 462
Zhang, Tu, Wang, Xu, Wan (CR73) 2014; 46
Bolzoni, Chiu, Accardi, Vescovini, Airoldi, Storti (CR9) 2016; 128
CR11
Zhang, Commisso (CR33) 2019; 5
Broer, Wagner (CR57) 2002; 36
Chen, Fei, Anderson, Wake, Miyauchi, Huang (CR69) 2003; 546
Lomelino, Andring, McKenna, Kilberg (CR1) 2017; 292
Liang, Zhang, Natarajan, Becker (CR52) 2013; 19
Bermudez Moretti, Correa Garcia, Perotti, Batlle, Casas (CR76) 2002; 87
Vande Voorde, Ackermann, Pfetzer, Sumpton, Mackay, Kalna (CR78) 2019; 5
Cantor, Abu-Remaileh, Kanarek, Freinkman, Gao, Louissaint (CR79) 2017; 169
Gupta, Sahu, Bomalaski, Frank, Boorjian, Thapa (CR4) 2018; 29
Kaul, Sharma, Mehta (CR51) 2008; 34
Meiser, Tumanov, Maddocks, Labuschagne, Athineos, Van Den Broek (CR64) 2016; 2
Lewis (CR28) 1937; 29
Hoque, Okuma, Banu, Nakamura, Shimoishi, Murata (CR50) 2007; 164
Garcia-Bermudez, Baudrier, La, Zhu, Fidelin, Sviderskiy (CR16) 2018; 20
Bertero, Oldham, Grasset, Bourget, Boulter, Pisano (CR23) 2019; 29
Newman, Maddocks (CR63) 2017; 27
Szlosarek, Klabatsa, Pallaska, Sheaff, Smith, Crook (CR5) 2006; 12
Doring, Walter, Will, Focking, Boll, Amasheh (CR77) 1998; 101
Dillon, Prieto, Curley, Ensor, Holtsberg, Bomalaski (CR3) 2004; 100
Ollenschlager, Roth, Linkesch, Jansen, Simmel, Modder (CR13) 1988; 18
Sousa, Biancur, Wang, Halbrook, Sherman, Zhang (CR41) 2016; 536
Furusawa, Miyamoto, Takano, Tsuda, Song, Aoki (CR10) 2018; 39
Bar-Sagi, Feramisco (CR29) 1986; 233
Sullivan, Gui, Hosios, Bush, Freinkman, Vander Heiden (CR26) 2015; 162
Richards, Kilberg (CR8) 2006; 75
620_CR11
AC Newman (620_CR63) 2017; 27
L Dang (620_CR44) 2009; 462
AK Groen (620_CR39) 1982; 122
IV Mohrenz (620_CR46) 2013; 18
J Garcia-Bermudez (620_CR16) 2018; 20
NG Richards (620_CR8) 2006; 75
O Olivares (620_CR36) 2017; 8
LB Sullivan (620_CR26) 2015; 162
MB Burg (620_CR67) 2008; 283
S Bisdas (620_CR45) 2016; 44
S Cardaci (620_CR18) 2015; 17
Z Chen (620_CR69) 2003; 546
SE Kohe (620_CR71) 2018; 9
CL Lomelino (620_CR1) 2017; 292
CJ Kelty (620_CR74) 2002; 1
M Bermudez Moretti (620_CR76) 2002; 87
M Martinez (620_CR37) 1993; 6
F Doring (620_CR77) 1998; 101
S Kaul (620_CR51) 2008; 34
G Ollenschlager (620_CR13) 1988; 18
OW Griffith (620_CR59) 1999; 27
Yijuan Zhang (620_CR33) 2019; 5
S Tardito (620_CR12) 2015; 17
R Khadeir (620_CR6) 2017; 8
M Yoshikawa (620_CR61) 2013; 73
BJ Dillon (620_CR3) 2004; 100
X Liang (620_CR52) 2013; 19
T Bertero (620_CR23) 2019; 29
Q Wu (620_CR34) 2013; 32
J Shi (620_CR47) 2015; 36
C Commisso (620_CR30) 2013; 497
I Elia (620_CR35) 2017; 8
C Lussey-Lepoutre (620_CR17) 2015; 6
J Vicente (620_CR72) 2013; 49
J Vande Voorde (620_CR78) 2019; 5
J Meiser (620_CR64) 2016; 2
L Yang (620_CR15) 2016; 24
JR Cantor (620_CR79) 2017; 169
G Bloomfield (620_CR27) 2016; 129
CM Sousa (620_CR41) 2016; 536
JB Spinelli (620_CR62) 2017; 358
J Meiser (620_CR65) 2018; 9
JJ Kamphorst (620_CR31) 2015; 75
WH Lewis (620_CR28) 1937; 29
DA Tennant (620_CR14) 2010; 10
EA Ehsanipour (620_CR22) 2013; 73
B Delage (620_CR19) 2012; 3
A Furusawa (620_CR10) 2018; 39
X Zhang (620_CR73) 2014; 46
LA Timmerman (620_CR60) 2013; 24
S Broer (620_CR57) 2002; 36
K Birsoy (620_CR25) 2015; 162
PW Szlosarek (620_CR5) 2006; 12
H Yan (620_CR43) 2009; 360
S Gupta (620_CR4) 2018; 29
Nydia Tejeda-Muñoz (620_CR32) 2019; 116
JM Mates (620_CR68) 2012; 4
D Bar-Sagi (620_CR29) 1986; 233
Z Wang (620_CR20) 2014; 98
P Nicklin (620_CR54) 2009; 136
S Bannai (620_CR56) 1980; 255
C Tiruppathi (620_CR70) 1992; 263
TT Tran (620_CR75) 2014; 90
L Szabados (620_CR48) 2010; 15
K Sugimura (620_CR2) 1992; 2
M Tajan (620_CR24) 2018; 28
EA Newsholme (620_CR38) 1985; 70
M Bolzoni (620_CR9) 2016; 128
J De Ingeniis (620_CR49) 2012; 7
AS Krall (620_CR55) 2016; 7
T Suzuki (620_CR66) 2002; 21
MM Phillips (620_CR7) 2013; 45
I Elia (620_CR40) 2019; 568
S Iwamoto (620_CR21) 2007; 117
M Lo (620_CR58) 2008; 99
KER Hollinshead (620_CR42) 2018; 22
A Broer (620_CR53) 2016; 291
MA Hoque (620_CR50) 2007; 164
References_xml – volume: 128
  start-page: 667
  year: 2016
  end-page: 679.
  ident: CR9
  article-title: Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
  publication-title: Blood
– volume: 162
  start-page: 552
  year: 2015
  end-page: 563.
  ident: CR26
  article-title: Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells
  publication-title: Cell
– volume: 122
  start-page: 87
  year: 1982
  end-page: 93
  ident: CR39
  article-title: Intracellular compartmentation and control of alanine metabolism in rat liver parenchymal cells
  publication-title: Eur. J. Biochem
– volume: 73
  start-page: 1855
  year: 2013
  end-page: 1866.
  ident: CR61
  article-title: xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma
  publication-title: Cancer Res.
– volume: 18
  start-page: 1416
  year: 2013
  end-page: 1425.
  ident: CR46
  article-title: Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death
  publication-title: Apoptosis
– volume: 6
  start-page: 1
  year: 1993
  end-page: 9
  ident: CR37
  article-title: Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer’s disease and vascular dementia
  publication-title: J. Neural Transm. Park Dis. Dement Sect.
– volume: 117
  start-page: 1049
  year: 2007
  end-page: 1057.
  ident: CR21
  article-title: Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
  publication-title: J. Clin. Invest
– volume: 7
  year: 2016
  ident: CR55
  article-title: Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
  publication-title: Nat. Commun.
– volume: 164
  start-page: 553
  year: 2007
  end-page: 561.
  ident: CR50
  article-title: Exogenous proline mitigates the detrimental effects of salt stress more than exogenous betaine by increasing antioxidant enzyme activities
  publication-title: J. Plant Physiol.
– volume: 49
  start-page: 658
  year: 2013
  end-page: 667.
  ident: CR72
  article-title: Accurate classification of childhood brain tumours by in vivo (1)H MRS - a multi-centre study
  publication-title: Eur. J. Cancer
– volume: 32
  start-page: 5541
  year: 2013
  end-page: 5550.
  ident: CR34
  article-title: Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma
  publication-title: Oncogene
– volume: 15
  start-page: 89
  year: 2010
  end-page: 97
  ident: CR48
  article-title: Proline: a multifunctional amino acid
  publication-title: Trends Plant Sci.
– volume: 7
  start-page: e45190
  year: 2012
  ident: CR49
  article-title: Functional specialization in proline biosynthesis of melanoma
  publication-title: PLoS One
– volume: 3
  year: 2012
  ident: CR19
  article-title: Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
  publication-title: Cell Death Dis.
– volume: 129
  start-page: 2697
  year: 2016
  end-page: 705.
  ident: CR27
  article-title: Uses and abuses of macropinocytosis
  publication-title: J. Cell Sci.
– volume: 21
  start-page: 6581
  year: 2002
  end-page: 6589
  ident: CR66
  article-title: Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases
  publication-title: EMBO J.
– volume: 99
  start-page: 464
  year: 2008
  end-page: 472.
  ident: CR58
  article-title: The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
  publication-title: Br. J. Cancer
– volume: 5
  start-page: eaau7314
  year: 2019
  ident: CR78
  article-title: Improving the metabolic fidelity of cancer models with a physiological cell culture medium
  publication-title: Sci. Adv.
– volume: 263
  start-page: G625
  year: 1992
  end-page: G631
  ident: CR70
  article-title: Constitutive expression of the taurine transporter in a human colon carcinoma cell line
  publication-title: Am. J. Physiol.
– volume: 73
  start-page: 2998
  year: 2013
  end-page: 3006
  ident: CR22
  article-title: Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine
  publication-title: Cancer Res.
– volume: 116
  start-page: 10402
  issue: 21
  year: 2019
  end-page: 10411
  ident: CR32
  article-title: Wnt canonical pathway activates macropinocytosis and lysosomal degradation of extracellular proteins
  publication-title: Proceedings of the National Academy of Sciences
– volume: 36
  start-page: 155
  year: 2002
  end-page: 168.
  ident: CR57
  article-title: Structure-function relationships of heterodimeric amino acid transporters
  publication-title: Cell Biochem. Biophys.
– volume: 2
  start-page: e1601273
  year: 2016
  ident: CR64
  article-title: Serine one-carbon catabolism with formate overflow
  publication-title: Sci. Adv.
– volume: 8
  start-page: 96468
  year: 2017
  end-page: 96469
  ident: CR6
  article-title: Optimizing arginine deprivation for hard-to-treat cancers
  publication-title: Oncotarget
– volume: 19
  start-page: 998
  year: 2013
  end-page: 1011
  ident: CR52
  article-title: Proline mechanisms of stress survival
  publication-title: Antioxid. Redox Signal
– volume: 8
  year: 2017
  ident: CR36
  article-title: Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
  publication-title: Nat. Commun.
– volume: 10
  start-page: 267
  year: 2010
  end-page: 277.
  ident: CR14
  article-title: Targeting metabolic transformation for cancer therapy
  publication-title: Nat. Rev. Cancer
– volume: 9
  year: 2018
  ident: CR65
  article-title: Increased formate overflow is a hallmark of oxidative cancer
  publication-title: Nat. Commun.
– volume: 28
  start-page: 721
  year: 2018
  end-page: 36 e6
  ident: CR24
  article-title: A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3
  publication-title: Cell Metab.
– volume: 233
  start-page: 1061
  year: 1986
  end-page: 1068
  ident: CR29
  article-title: Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins
  publication-title: Science
– volume: 12
  start-page: 7126
  year: 2006
  end-page: 7131.
  ident: CR5
  article-title: In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
  publication-title: Clin. Cancer Res
– volume: 2
  start-page: 191
  year: 1992
  end-page: 196
  ident: CR2
  article-title: High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro
  publication-title: Melanoma Res.
– ident: CR11
– volume: 462
  start-page: 739
  year: 2009
  end-page: 744.
  ident: CR44
  article-title: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
  publication-title: Nature
– volume: 29
  start-page: 236
  year: 2018
  end-page: 841.
  ident: CR4
  article-title: Argininosuccinate synthetase-1 (ASS1) loss in high-grade neuroendocrine carcinomas of the urinary bladder: implications for targeted therapy with ADI-PEG 20
  publication-title: Endocr. Pathol.
– volume: 29
  start-page: 666
  year: 1937
  end-page: 679
  ident: CR28
  article-title: Pinocytosis by malignant cells
  publication-title: Am. J. Cancer
– volume: 75
  start-page: 544
  year: 2015
  end-page: 553.
  ident: CR31
  article-title: Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein
  publication-title: Cancer Res.
– volume: 169
  start-page: 258
  year: 2017
  end-page: 272 e17
  ident: CR79
  article-title: Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase
  publication-title: Cell
– volume: 255
  start-page: 2372
  year: 1980
  end-page: 2376
  ident: CR56
  article-title: Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture
  publication-title: J. Biol. Chem.
– volume: 358
  start-page: 941
  year: 2017
  end-page: 946
  ident: CR62
  article-title: Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
  publication-title: Science
– volume: 44
  start-page: 823
  year: 2016
  end-page: 833.
  ident: CR45
  article-title: MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T
  publication-title: J. Magn. Reson Imaging
– volume: 24
  start-page: 450
  year: 2013
  end-page: 465.
  ident: CR60
  article-title: Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target
  publication-title: Cancer Cell.
– volume: 360
  start-page: 765
  year: 2009
  end-page: 773.
  ident: CR43
  article-title: IDH1 and IDH2 mutations in gliomas
  publication-title: N. Engl. J. Med
– volume: 291
  start-page: 13194
  year: 2016
  end-page: 13205.
  ident: CR53
  article-title: Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells
  publication-title: J. Biol. Chem.
– volume: 136
  start-page: 521
  year: 2009
  end-page: 534.
  ident: CR54
  article-title: Bidirectional transport of amino acids regulates mTOR and autophagy
  publication-title: Cell
– volume: 1
  start-page: 158
  year: 2002
  end-page: 168.
  ident: CR74
  article-title: The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis
  publication-title: Photochem Photobio. Sci.
– volume: 27
  start-page: 922
  year: 1999
  end-page: 935.
  ident: CR59
  article-title: Biologic and pharmacologic regulation of mammalian glutathione synthesis
  publication-title: Free Radic. Biol. Med
– volume: 36
  start-page: 655
  year: 2015
  end-page: 662.
  ident: CR47
  article-title: Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation
  publication-title: Tumour Biol.
– volume: 46
  start-page: 261
  year: 2014
  end-page: 272.
  ident: CR73
  article-title: Mechanism of taurine-induced apoptosis in human colon cancer cells
  publication-title: Acta Biochim Biophys. Sin. (Shanghai)
– volume: 568
  start-page: 117
  year: 2019
  end-page: 121.
  ident: CR40
  article-title: Breast cancer cells rely on environmental pyruvate to shape the metastatic niche
  publication-title: Nature
– volume: 90
  start-page: 1136
  year: 2014
  end-page: 1143
  ident: CR75
  article-title: Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells
  publication-title: Photochem Photobiol.
– volume: 34
  start-page: 315
  year: 2008
  end-page: 320.
  ident: CR51
  article-title: Free radical scavenging potential of L-proline: evidence from in vitro assays
  publication-title: Amino Acids
– volume: 87
  start-page: 471
  year: 2002
  end-page: 474
  ident: CR76
  article-title: Delta-aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters
  publication-title: Br. J. Cancer
– volume: 100
  start-page: 826
  year: 2004
  end-page: 833.
  ident: CR3
  article-title: Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation
  publication-title: Cancer
– volume: 20
  start-page: 775
  year: 2018
  end-page: 781.
  ident: CR16
  article-title: Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
  publication-title: Nat. Cell Biol.
– volume: 8
  year: 2017
  ident: CR35
  article-title: Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells
  publication-title: Nat. Commun.
– volume: 22
  start-page: 3107
  year: 2018
  end-page: 3114.
  ident: CR42
  article-title: Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis
  publication-title: Cell Rep.
– volume: 24
  start-page: 685
  year: 2016
  end-page: 700
  ident: CR15
  article-title: Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth
  publication-title: Cell Metab.
– volume: 536
  start-page: 479
  year: 2016
  end-page: 483.
  ident: CR41
  article-title: Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
  publication-title: Nature
– volume: 6
  year: 2015
  ident: CR17
  article-title: Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism
  publication-title: Nat. Commun.
– volume: 9
  start-page: 11336
  year: 2018
  end-page: 11351.
  ident: CR71
  article-title: Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles
  publication-title: Oncotarget
– volume: 101
  start-page: 2761
  year: 1998
  end-page: 2767
  ident: CR77
  article-title: Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications
  publication-title: J. Clin. Invest
– volume: 4
  start-page: 722
  year: 2012
  end-page: 748
  ident: CR68
  article-title: Sulphur-containing non enzymatic antioxidants: therapeutic tools against cancer
  publication-title: Front. Biosci. (Schol Ed).
– volume: 75
  start-page: 629
  year: 2006
  end-page: 654.
  ident: CR8
  article-title: Asparagine synthetase chemotherapy
  publication-title: Annu Rev. Biochem
– volume: 39
  start-page: 758
  year: 2018
  end-page: 766.
  ident: CR10
  article-title: Ovarian cancer therapeutic potential of glutamine depletion based on GS expression
  publication-title: Carcinogenesis
– volume: 17
  start-page: 1317
  year: 2015
  end-page: 1326.
  ident: CR18
  article-title: Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis
  publication-title: Nat. Cell Biol.
– volume: 70
  start-page: 473
  year: 1985
  end-page: 489.
  ident: CR38
  article-title: Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance
  publication-title: Q J. Exp. Physiol.
– volume: 18
  start-page: 512
  year: 1988
  end-page: 516
  ident: CR13
  article-title: Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects
  publication-title: Eur. J. Clin. Invest
– volume: 283
  start-page: 7309
  year: 2008
  end-page: 7313.
  ident: CR67
  article-title: Intracellular organic osmolytes: function and regulation
  publication-title: J. Biol. Chem.
– volume: 27
  start-page: 645
  year: 2017
  end-page: 657.
  ident: CR63
  article-title: Serine and Functional Metabolites in Cancer
  publication-title: Trends Cell Biol.
– volume: 29
  start-page: 124
  year: 2019
  end-page: 40 e10
  ident: CR23
  article-title: Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy
  publication-title: Cell Metab.
– volume: 292
  start-page: 19952
  year: 2017
  end-page: 19958
  ident: CR1
  article-title: Asparagine synthetase: function, structure, and role in disease
  publication-title: J. Biol. Chem.
– volume: 98
  start-page: 2485
  year: 2014
  end-page: 2494.
  ident: CR20
  article-title: Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells
  publication-title: Appl. Microbiol. Biotechnol.
– volume: 45
  start-page: 251
  year: 2013
  end-page: 262.
  ident: CR7
  article-title: Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges
  publication-title: Cancer Res Treat.
– volume: 546
  start-page: 349
  year: 2003
  end-page: 361.
  ident: CR69
  article-title: Structure, function and immunolocalization of a proton-coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco-2
  publication-title: J. Physiol.
– volume: 17
  start-page: 1556
  year: 2015
  end-page: 1568.
  ident: CR12
  article-title: Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
  publication-title: Nat. Cell Biol.
– volume: 162
  start-page: 540
  year: 2015
  end-page: 551.
  ident: CR25
  article-title: An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis
  publication-title: Cell
– volume: 497
  start-page: 633
  year: 2013
  end-page: 637
  ident: CR30
  article-title: Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
  publication-title: Nature
– volume: 5
  start-page: 332
  issue: 6
  year: 2019
  end-page: 334
  ident: CR33
  article-title: Macropinocytosis in Cancer: A Complex Signaling Network
  publication-title: Trends in Cancer
– volume: 98
  start-page: 2485
  year: 2014
  ident: 620_CR20
  publication-title: Appl. Microbiol. Biotechnol.
  doi: 10.1007/s00253-013-5118-0
– volume: 462
  start-page: 739
  year: 2009
  ident: 620_CR44
  publication-title: Nature
  doi: 10.1038/nature08617
– volume: 73
  start-page: 1855
  year: 2013
  ident: 620_CR61
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-3609-T
– volume: 7
  year: 2016
  ident: 620_CR55
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms11457
– volume: 128
  start-page: 667
  year: 2016
  ident: 620_CR9
  publication-title: Blood
  doi: 10.1182/blood-2016-01-690743
– volume: 22
  start-page: 3107
  year: 2018
  ident: 620_CR42
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2018.02.084
– volume: 117
  start-page: 1049
  year: 2007
  ident: 620_CR21
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI30235
– volume: 7
  start-page: e45190
  year: 2012
  ident: 620_CR49
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0045190
– volume: 164
  start-page: 553
  year: 2007
  ident: 620_CR50
  publication-title: J. Plant Physiol.
  doi: 10.1016/j.jplph.2006.03.010
– volume: 34
  start-page: 315
  year: 2008
  ident: 620_CR51
  publication-title: Amino Acids
  doi: 10.1007/s00726-006-0407-x
– volume: 18
  start-page: 512
  year: 1988
  ident: 620_CR13
  publication-title: Eur. J. Clin. Invest
  doi: 10.1111/j.1365-2362.1988.tb01049.x
– volume: 5
  start-page: 332
  issue: 6
  year: 2019
  ident: 620_CR33
  publication-title: Trends in Cancer
  doi: 10.1016/j.trecan.2019.04.002
– volume: 122
  start-page: 87
  year: 1982
  ident: 620_CR39
  publication-title: Eur. J. Biochem
  doi: 10.1111/j.1432-1033.1982.tb05851.x
– volume: 45
  start-page: 251
  year: 2013
  ident: 620_CR7
  publication-title: Cancer Res Treat.
  doi: 10.4143/crt.2013.45.4.251
– volume: 536
  start-page: 479
  year: 2016
  ident: 620_CR41
  publication-title: Nature
  doi: 10.1038/nature19084
– volume: 255
  start-page: 2372
  year: 1980
  ident: 620_CR56
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)85901-X
– volume: 358
  start-page: 941
  year: 2017
  ident: 620_CR62
  publication-title: Science
  doi: 10.1126/science.aam9305
– volume: 568
  start-page: 117
  year: 2019
  ident: 620_CR40
  publication-title: Nature
  doi: 10.1038/s41586-019-0977-x
– volume: 27
  start-page: 922
  year: 1999
  ident: 620_CR59
  publication-title: Free Radic. Biol. Med
  doi: 10.1016/S0891-5849(99)00176-8
– volume: 360
  start-page: 765
  year: 2009
  ident: 620_CR43
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMoa0808710
– volume: 19
  start-page: 998
  year: 2013
  ident: 620_CR52
  publication-title: Antioxid. Redox Signal
  doi: 10.1089/ars.2012.5074
– volume: 20
  start-page: 775
  year: 2018
  ident: 620_CR16
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-018-0118-z
– volume: 8
  year: 2017
  ident: 620_CR36
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms16031
– volume: 291
  start-page: 13194
  year: 2016
  ident: 620_CR53
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M115.700534
– volume: 4
  start-page: 722
  year: 2012
  ident: 620_CR68
  publication-title: Front. Biosci. (Schol Ed).
  doi: 10.2741/s296
– volume: 1
  start-page: 158
  year: 2002
  ident: 620_CR74
  publication-title: Photochem Photobio. Sci.
  doi: 10.1039/b201027p
– volume: 6
  year: 2015
  ident: 620_CR17
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms9784
– volume: 90
  start-page: 1136
  year: 2014
  ident: 620_CR75
  publication-title: Photochem Photobiol.
  doi: 10.1111/php.12290
– volume: 46
  start-page: 261
  year: 2014
  ident: 620_CR73
  publication-title: Acta Biochim Biophys. Sin. (Shanghai)
  doi: 10.1093/abbs/gmu004
– volume: 6
  start-page: 1
  year: 1993
  ident: 620_CR37
  publication-title: J. Neural Transm. Park Dis. Dement Sect.
  doi: 10.1007/BF02252617
– volume: 75
  start-page: 544
  year: 2015
  ident: 620_CR31
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-14-2211
– volume: 162
  start-page: 540
  year: 2015
  ident: 620_CR25
  publication-title: Cell
  doi: 10.1016/j.cell.2015.07.016
– volume: 5
  start-page: eaau7314
  year: 2019
  ident: 620_CR78
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aau7314
– volume: 17
  start-page: 1317
  year: 2015
  ident: 620_CR18
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb3233
– volume: 36
  start-page: 155
  year: 2002
  ident: 620_CR57
  publication-title: Cell Biochem. Biophys.
  doi: 10.1385/CBB:36:2-3:155
– volume: 21
  start-page: 6581
  year: 2002
  ident: 620_CR66
  publication-title: EMBO J.
  doi: 10.1093/emboj/cdf656
– volume: 546
  start-page: 349
  year: 2003
  ident: 620_CR69
  publication-title: J. Physiol.
  doi: 10.1113/jphysiol.2002.026500
– volume: 8
  year: 2017
  ident: 620_CR35
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms15267
– volume: 36
  start-page: 655
  year: 2015
  ident: 620_CR47
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-014-2644-z
– volume: 9
  start-page: 11336
  year: 2018
  ident: 620_CR71
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24168
– volume: 263
  start-page: G625
  year: 1992
  ident: 620_CR70
  publication-title: Am. J. Physiol.
– volume: 12
  start-page: 7126
  year: 2006
  ident: 620_CR5
  publication-title: Clin. Cancer Res
  doi: 10.1158/1078-0432.CCR-06-1101
– volume: 49
  start-page: 658
  year: 2013
  ident: 620_CR72
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2012.09.003
– volume: 24
  start-page: 685
  year: 2016
  ident: 620_CR15
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2016.10.011
– volume: 233
  start-page: 1061
  year: 1986
  ident: 620_CR29
  publication-title: Science
  doi: 10.1126/science.3090687
– volume: 39
  start-page: 758
  year: 2018
  ident: 620_CR10
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgy033
– volume: 129
  start-page: 2697
  year: 2016
  ident: 620_CR27
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.176149
– volume: 2
  start-page: 191
  year: 1992
  ident: 620_CR2
  publication-title: Melanoma Res.
  doi: 10.1097/00008390-199209000-00007
– volume: 101
  start-page: 2761
  year: 1998
  ident: 620_CR77
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI1909
– volume: 8
  start-page: 96468
  year: 2017
  ident: 620_CR6
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.22099
– volume: 27
  start-page: 645
  year: 2017
  ident: 620_CR63
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2017.05.001
– volume: 75
  start-page: 629
  year: 2006
  ident: 620_CR8
  publication-title: Annu Rev. Biochem
  doi: 10.1146/annurev.biochem.75.103004.142520
– volume: 17
  start-page: 1556
  year: 2015
  ident: 620_CR12
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb3272
– volume: 18
  start-page: 1416
  year: 2013
  ident: 620_CR46
  publication-title: Apoptosis
  doi: 10.1007/s10495-013-0877-8
– volume: 10
  start-page: 267
  year: 2010
  ident: 620_CR14
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2817
– volume: 29
  start-page: 124
  year: 2019
  ident: 620_CR23
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2018.09.012
– volume: 9
  year: 2018
  ident: 620_CR65
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03777-w
– volume: 100
  start-page: 826
  year: 2004
  ident: 620_CR3
  publication-title: Cancer
  doi: 10.1002/cncr.20057
– volume: 15
  start-page: 89
  year: 2010
  ident: 620_CR48
  publication-title: Trends Plant Sci.
  doi: 10.1016/j.tplants.2009.11.009
– volume: 99
  start-page: 464
  year: 2008
  ident: 620_CR58
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6604485
– volume: 497
  start-page: 633
  year: 2013
  ident: 620_CR30
  publication-title: Nature
  doi: 10.1038/nature12138
– volume: 292
  start-page: 19952
  year: 2017
  ident: 620_CR1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R117.819060
– volume: 70
  start-page: 473
  year: 1985
  ident: 620_CR38
  publication-title: Q J. Exp. Physiol.
  doi: 10.1113/expphysiol.1985.sp002935
– volume: 29
  start-page: 666
  year: 1937
  ident: 620_CR28
  publication-title: Am. J. Cancer
  doi: 10.1158/ajc.1937.510
– volume: 32
  start-page: 5541
  year: 2013
  ident: 620_CR34
  publication-title: Oncogene
  doi: 10.1038/onc.2013.264
– volume: 44
  start-page: 823
  year: 2016
  ident: 620_CR45
  publication-title: J. Magn. Reson Imaging
  doi: 10.1002/jmri.25221
– volume: 87
  start-page: 471
  year: 2002
  ident: 620_CR76
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6600481
– volume: 169
  start-page: 258
  year: 2017
  ident: 620_CR79
  publication-title: Cell
  doi: 10.1016/j.cell.2017.03.023
– ident: 620_CR11
  doi: 10.3390/ijms19041099
– volume: 136
  start-page: 521
  year: 2009
  ident: 620_CR54
  publication-title: Cell
  doi: 10.1016/j.cell.2008.11.044
– volume: 3
  year: 2012
  ident: 620_CR19
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2012.83
– volume: 29
  start-page: 236
  year: 2018
  ident: 620_CR4
  publication-title: Endocr. Pathol.
  doi: 10.1007/s12022-018-9516-9
– volume: 116
  start-page: 10402
  issue: 21
  year: 2019
  ident: 620_CR32
  publication-title: Proceedings of the National Academy of Sciences
  doi: 10.1073/pnas.1903506116
– volume: 28
  start-page: 721
  year: 2018
  ident: 620_CR24
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2018.07.005
– volume: 162
  start-page: 552
  year: 2015
  ident: 620_CR26
  publication-title: Cell
  doi: 10.1016/j.cell.2015.07.017
– volume: 283
  start-page: 7309
  year: 2008
  ident: 620_CR67
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R700042200
– volume: 73
  start-page: 2998
  year: 2013
  ident: 620_CR22
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-4402
– volume: 2
  start-page: e1601273
  year: 2016
  ident: 620_CR64
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.1601273
– volume: 24
  start-page: 450
  year: 2013
  ident: 620_CR60
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccr.2013.08.020
SSID ssj0009087
Score 2.6822612
SecondaryResourceType review_article
Snippet An abundant supply of amino acids is important for cancers to sustain their proliferative drive. Alongside their direct role as substrates for protein...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 150
SubjectTerms 631/67/2327
631/67/327
Amino acids
Amino Acids - genetics
Amino Acids - metabolism
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer Research
Cell Proliferation - genetics
Drug Resistance
Energy Metabolism - genetics
Epidemiology
Humans
Metabolism
Molecular Medicine
Neoplasms - genetics
Neoplasms - metabolism
Oncology
Protein biosynthesis
Protein Biosynthesis - genetics
Review
Review Article
Tumor Microenvironment - genetics
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB7RRUK9VOXRkhaQK3ECpU1iO7GPaMUKIcGpSNwix7HVSGwWscv_Z8Z5oGVVJC65eJI4M_Z4xuPvC8ApuX1cVWxcO2liYYyLtcHEVXjrCJEmeEC939zmV3fi-l7eb0E6YGHCof1AaRnc9HA67M9SpBg6YOJLmHnMeOQn2Cbmdsq3pvn0lWc3UR1NJu3A6WwsZHK1-Yj1pWgjvtw8JvmmVhqWoNlX-NLHjuyi6-0ubLl2D3Zu-ur4PvxGj8VMwE4u2cIzM2_aBTO2qdncrdDaD81yzpqWWTL10wHczS7_Tq_i_n8IsZU8X8XCUUqpjeV1Uknha19laZUT1FV65bSu61QLaYV2znOPEhmXiVV1jpNUKsW_waRdtO4QmMut9TZLLaFD0tTqSqWOyPm8qERV6AiSQTWl7cnC6Z8VD2UoWnNVdtosUZslabOUEZyNtzx2TBnvCR8N-i77SbMsMy44hmB4jeDX2IzDnWoYpnWLZ5JBqQKdUBbB984849vQPWH2qYoIijXDjQJEpb3e0jb_AqV2kUhi1ovgfDDxa7f--xE_PiT9Ez5nlKuH7ZsjmKyent0xBjSr6iQM4Rerxusq
  priority: 102
  providerName: Springer Nature
Title New aspects of amino acid metabolism in cancer
URI https://link.springer.com/article/10.1038/s41416-019-0620-5
https://www.ncbi.nlm.nih.gov/pubmed/31819187
https://www.proquest.com/docview/2343025343
https://www.proquest.com/docview/2323472252
https://pubmed.ncbi.nlm.nih.gov/PMC7052246
Volume 122
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9wwDBdrC6MvY59ttrZ4sKeNrElsJ_bT6B09yqDHKC3cW3AcmwZ6Sddc__9JSS7HrbQvCcQKiSVbsizrJ4BvpPbRqtiwdNKEwhgXaoOOq_DWUUaa4F3W--U8vbgRvxdyMWy4tcOxyrVO7BR12VjaIz9NuOBon_H66_5vSFWjKLo6lNDYgT2CLqNRnS2yDehupHrMTNqO08kY1eTqtBUxLkXQkaYcfPSg5LZderLYfHpm8r_AaWePZm_hzbCQZGe95N_BK1e_h9eXQ6j8A_xE9cVMl0jZssYzs6zqhhlblWzpVij6u6pdsqpmluT-8BFuZufX04twKI4QWsnTVSgc-ZfaWF5GhRS-9EUSFynlvUqvnNZlGWshrdDOee6RIuEysqpMccZKpfgn2K2b2h0Cc6m13iaxpVSROLa6ULEjpD4vClFkOoBozZrcDsjhVMDiLu8i2FzlPTdz5GZO3MxlAN_HV-572IyXiI_W_M6HGdTmG3kH8HVsxrFPAQ1Tu-aRaJAqQ42UBHDQi2f8GuoqdEVVFkC2JbiRgHC1t1vq6rbD184iSTB7AfxYi3jzW8924vPLnfgC-wl56t3mzRHsrh4e3TEuZ1bFSTdm8aqm8Qnsnc0mkzneJ-fzP1f4dJpO_wH8jfKE
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKBFwQbwIFjAQXUGgS24l9QAgVqi3t9tRKvQXHsUWkblKarRA_xTcyk9dqqeitl1wyeXienhnPDMAbUvtoVWxYOmlCYYwLtUHHVXjrqCJN8K7qfX6Yzo7FtxN5sgF_xloYOlY56sROUZeNpRj5dsIFR_uM109nP0OaGkXZ1XGERs8W--73L3TZ2o97X5C-b5Nk9-vRziwcpgqEVvJ0GQpHjpk2lpdRIYUvfZHERUoFo9Irp3VZomMvrdDOee4RIuEysqpMkdWlUhzfewNuCo6iSZXpO6sjJTpSfY9OCv_pZMqicrXdihi3Pui4U80_emxy3Q5e2txePqP5T6K2s3-79-DusHFln3tOuw8brn4At-ZDav4hfEB1yUxXuNmyxjOzqOqGGVuVbOGWyGqnVbtgVc0s8dn5Izi-FrQ9hs26qd1TYC611tsktlSaEsdWFyp21BnQi0IUmQ4gGlGT26FTOQ3MOM27jDlXeY_NHLGZEzZzGcC76ZGzvk3HVcBbI77zQWLbfMVfAbyebqOsUQLF1K65IBiEylADJgE86ckzfQ11I7q-KgsgWyPcBEB9vNfv1NWPrp93Fklq6xfA-5HEq9_67yKeXb2IV3B7djQ_yA_2Dvefw52EogRd4GgLNpfnF-4FbqWWxcuOfxl8v26B-QuOJynC
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKVHFBvAkUMBJcQGGT2E7sA0KoZdVSWnGgUm_BcWwRqZuUZivEr_F1zOS1Wip66yWXTB4ez_tlgFck9lGr2LB00oTCGBdqg46r8NZRR5rgXdf74VG6dyw-n8iTDfgz9sJQWeUoEztBXTaWYuSzhAuO-hmvMz-URXzdnX84-xnSCVKUaR2P0-hJ5MD9_oXuW_t-fxf3-nWSzD9929kLhxMGQit5ugyFIydNG8vLqJDCl75I4iKl5lHpldO6LNHJl1Zo5zz3CJFwGVlVpkj2UimO770BNzOeKeIxtbMqL9GR6ud1UihQJ1NGlatZK2I0g9CJp_5_9N7kuk68ZOhertf8J2nb6cL5Hbg9GLHsY091d2HD1fdg63BI09-Hdyg6memaOFvWeGYWVd0wY6uSLdwSye60ahesqpklmjt_AMfXgraHsFk3tXsMzKXWepvEltpU4tjqQsWOpgR6UYgi0wFEI2pyO0wtp8MzTvMue85V3mMzR2zmhM1cBvBmeuSsH9lxFfD2iO984N42X9FaAC-n28h3lEwxtWsuCAahMpSGSQCP-u2ZvoZyEt1glQWQrW3cBEAzvdfv1NWPbrZ3Fkka8RfA23GLV7_130U8uXoRL2ALWSX_sn908BRuJRQw6GJI27C5PL9wz9CqWhbPO_Jl8P26-eUvpaAt-A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+aspects+of+amino+acid+metabolism+in+cancer&rft.jtitle=British+journal+of+cancer&rft.au=Vettore%2C+Lisa&rft.au=Westbrook%2C+Rebecca+L&rft.au=Tennant%2C+Daniel+A&rft.date=2020-01-01&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=122&rft.issue=2&rft.spage=150&rft.epage=156&rft_id=info:doi/10.1038%2Fs41416-019-0620-5&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon